Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers ; volume:50 ; number:2 ; day:11 ; month:3 ; year:2023 ; pages:213-220 ; date:4.2023
Journal of medical ultrasonics ; 50, Heft 2 (11.3.2023), 213-220, 4.2023
- Urheber
-
Ikejima, Kengo
Tokioka, Sayuri
Yagishita, Kazuyo
Kajiura, Yuka
Kanomata, Naoki
Yamauchi, Hideko
Kurihara, Yasuyuki
Tsunoda, Hiroko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10396-023-01296-w
- URN
-
urn:nbn:de:101:1-2023091013304585238187
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ikejima, Kengo
- Tokioka, Sayuri
- Yagishita, Kazuyo
- Kajiura, Yuka
- Kanomata, Naoki
- Yamauchi, Hideko
- Kurihara, Yasuyuki
- Tsunoda, Hiroko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers